Ocular Therapeutix is making sure its corporate vision is 20/20 as it looks forward to phase 3 data on its eye disease drug candidate Axpaxli. | Ocular Therapeutix is making sure its corporate vision ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

Most gene therapies being studied for eye diseases are in earlier phases of development, and a third of the gene therapies ...

Retinal artery occlusion, or eye stroke, can cause sudden and permanent vision loss. Learn about its causes, symptoms, and treatment.

That was in 2011. But it’s a whole different ball game now. There are so many more studies and clinical trials being done and there’s more awareness about inherited retinal dystrophy. There ...

North Carolina-based Atsena secured a $150 million series C in early April to fund ATSN-201’s clinical development. The company is also progressing a gene therapy for the severe retinal disease ...

Inside the human eye, the retina is made up of several types of cells, including the light-sensing photoreceptors that initiate the cascade of events that lead to vision. Skip to content Menu ...

When doctors examined the retina, the affected blood vessels looked a bit like the frosted branches of a tree, hence the name ...

Generally, you won't be using the drops long enough to experience severe side effects. Vision Problems and Medications ...

Scientists used patient stem cells and 3D bioprinting to produce eye tissue that will advance understanding of the mechanisms of blinding diseases. The research team printed a combination of cells ...